Safety and Efficacy of Low Dose MM-120 for ADHD Proof of Concept Trial
Status:
Recruiting
Trial end date:
2023-11-27
Target enrollment:
Participant gender:
Summary
This study measures the safety and efficacy of repeated low dose MM-120 as treatment for ADHD
in adults: a multi-center, randomized, double-blind, placebo-controlled